Terns Pharmaceuticals, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
TERN on Nasdaq
Industry
Pharmaceutical Preparations
Location
1065 East Hillsdale Blvd., Suite 100, Foster City, CA

Insiders trading volume in the past year

Terns Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vivo Opportunity, LLC 10%+ Owner $38.7M -$2.8M -6.74% Apr 1, 2024
Orbimed Advisors Llc Director, 10%+ Owner $7.56M -$562K -6.92% Jul 15, 2024
Carl L. Gordon Director, 10%+ Owner $7.56M -$562K -6.92% Jul 15, 2024
LAV Biosciences Fund V, L.P. 10%+ Owner $2M Nov 23, 2022
Mark J. Vignola Chief Financial Officer $1.01M -$85.9K -7.83% Sep 10, 2024
Seokho Bryan Yoon COO and General Counsel $408K +$24.1K +6.27% May 31, 2024
Erin Quirk President, Head of R&D $284K Jan 23, 2024
Emil Kuriakose Chief Medical Officer $222K Mar 10, 2024
Jill M. Quigley Director $150K -$434K -74.3% Sep 9, 2024
Senthil Sundaram Chief Executive Officer, Director $36.9K May 31, 2023
Hongbo Lu Director Jul 1, 2024
Melita Sun Jung Chief Business Officer May 1, 2024
David A. Fellows Director Jul 1, 2024
Radhika Tripuraneni Director Jul 1, 2024
Jeffrey B. Kindler Director Jul 1, 2024
Amy L. Burroughs Chief Executive Officer, Director Mar 1, 2024
Ann Elizabeth Taylor Director Jul 1, 2024
Kerry Strong Russell Chief Medical Officer Jul 1, 2022

Recent Insider Transactions by Companies or Individuals for Terns Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.